Navigation Links
Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery

Data to be Presented at the XXI Congress of the International Society on Thrombosis and Haemostasis

SOUTH SAN FRANCISCO, Calif., April 04, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. today announced that it has received positive results from EXPERT, a Phase II study of its oral Factor Xa inhibitor, PRT054021, for the prevention of venous thromboembolism (VTE) following total knee replacement (TKR) surgery. Based on these results, Portola will advance PRT054021 into further clinical testing.

"Successful completion of EXPERT is a significant achievement and is the result of many years of work by the Portola team in the field of anticoagulants," said Charles Homcy, M.D., CEO of Portola. "We are pleased that the results of this study are consistent with our predicted therapeutic dose range for PRT054021."

EXPERT (Evaluation of the Factor Xa Inhibitor, PRT054021, against Enoxaparin in a Randomized Trial for the Prevention of Venous Thromboembolic Events after Unilateral Total Knee Replacement) enrolled over 200 patients at 20 medical centers in the United States and Canada in a randomized, active comparator, parallel-group trial. Patients were randomized to receive one of two oral doses of PRT054021, or Lovenox(R) (enoxaparin) given as a subcutaneous injection. The treatment period was for ten to fourteen days after surgery, at which time a venogram was obtained to determine the presence of VTE.

The EXPERT steering committee, which includes a group of leading physicians and orthopedic surgeons with significant experience in conducting clinical trials involving novel anticoagulants, determined that EXPERT met its objectives: PRT054021 appeared effective and safe at the two doses studied, and the results support advancing the compound into further clinical trials. Data from EXPERT will be presented at the XXI Congress of the International Society on Thrombosis and Haemostasis in Geneva, Swi
'"/>




Page: 1 2 3

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
3. Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP Receptor Antagonist at the American College of Cardiology
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:7/29/2014)... New high priced hepatitis C drugs will ... projected $2.9 to $5.8 billion next year, according to ... today by the Pharmaceutical Care Management Association (PCMA). Milliman ... as much as 8.6 percent in 2015 as a ... Olysio. The study finds that the majority ...
(Date:7/29/2014)... , July 29, 2014 ... Market Research "Surgical Navigation Systems Market (Neurosurgical Navigation Systems, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 ... valued at USD 218.5 million in 2013 and is ... 2014 to 2020, to reach an estimated value of ...
(Date:7/29/2014)... , July 29, 2014 New technology in ... could allow physicians to see and assess brain tissue ... according to study authors who released their findings today ... Annual Meeting in Colorado Springs, CO. ... the field of neurointervention, a specialty that facilitates stroke ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3
... Feb. 28, 2012  BioStorage Technologies, a global provider ... industry, including storage, cold chain logistics and virtual ... include sample preparation services. New ... verification, as well as PBMC (Peripheral Blood Mononuclear ...
... HistoRx, the leader in quantitative immunohistochemistry, has earned ... elements of digital microscopy standardization.  Combined with patents ... & Trademark Office advance the Company,s proprietary position ... dominant role in the industry.  ...
Cached Medicine Technology:BioStorage Technologies Integrates Sample Preparation Services into European Operations 2HistoRx Achieves Dominant Intellectual Property Position in Standardization of Results from Digital Pathology Instruments 2HistoRx Achieves Dominant Intellectual Property Position in Standardization of Results from Digital Pathology Instruments 3
(Date:7/29/2014)... NY (PRWEB) July 29, 2014 The National ... have sent a letter to Washington NFL team owner Dan ... opposition to the R-word racial slur is emanating from “well-intentioned ... team and Snyder have yet to respond. , ... full text of the letter, which was first reported ...
(Date:7/29/2014)... Los Angeles, CA (PRWEB) July 29, 2014 ... of the temporary fix provided by energy drinks. ... boost in cognitive nutrition that creates optimal conditions for ... the brain healthy. truBrain hopes to raise $50,000 over ... provide a more stable mental boost and have compounding ...
(Date:7/29/2014)... The report “Filling Equipment Market by ... Aseptic, Net Weight), Process (Manual, Semi-Automatic, Automatic), Product ... & Forecast to 2019”, defines the filling equipment ... and cosmetic segments with analyses and projections of ... in terms of value. It also identifies the ...
(Date:7/29/2014)... York and London (PRWEB) July 29, 2014 ... focused provider of Computer Aided Engineering software, ... Device Innovation Consortium (MDIC), the first public-private partnership ... medical device community. MDIC made tremendous progress in ... players in the field of Computational Modeling ...
(Date:7/29/2014)... Florida (PRWEB) July 29, 2014 ... signs of tripling in the number of hospitals ... October 1, 2015 deadline, according to the recently ... and physician leaders, found in the reports “Top ... of hospitals now outsource Clinical documentation audit, review ...
Breaking Medicine News(10 mins):Health News:Native American Groups Urge Washington Team Owner Dan Snyder to Stop Claiming Name Change Issue Driven by "Elites" Who Are Not People of Color 2Health News:Focus- and Productivity-Enhancing Beverage Launches Crowdfunding Campaign on Indiegogo 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4Health News:CD-adapco Helps Advance the Use of Simulation in Medical Device Industry 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 3
... HealthDay Reporter , THURSDAY, May 19 (HealthDay News) -- ... accident has been able to stand up by himself, move ... a treadmill, thanks to electrical stimulation of his lower spinal ... -- mimics signals the brain normally sends to start movement. ...
... , THURSDAY, May 19 (HealthDay News) -- The U.S. Food ... Avandia will no longer be sold at retail pharmacies beginning ... patients. According to the new rules, which will go ... available to patients who,ve been safely using the drug, ...
... (HealthDay News) -- Hispanic women who suffer domestic abuse ... increased risk of postpartum depression, U.S. researchers say. ... stronger predictor of postpartum depression than prenatal depression, which ... The study of 210 Hispanic women aged 18 ...
... York, NY, May 19, 2011 The Children,s Health ... set of recommended health care quality measures to be ... Children,s Health Insurance Programs (CHIP), which together cover almost ... Supplement to Academic Pediatrics, the official journal of the ...
... , THURSDAY, May 19 (HealthDay News) -- Summer ... family gets swimmer,s ear, a common infection that accounts for ... to a new government report. Swimmer,s ear results ... each visit costing an average of $200, according to the ...
... WEDNESDAY, May 18 (HealthDay News) -- Women 30 and older ... cancer tests available today can safely wait three years for ... new research. The finding is not likely be controversial, ... White Healthcare in Temple, Texas, given that most current guidelines ...
Cached Medicine News:Health News:Spinal Stimulation Helps Paralyzed Man Regain Movement 2Health News:Spinal Stimulation Helps Paralyzed Man Regain Movement 3Health News:Spinal Stimulation Helps Paralyzed Man Regain Movement 4Health News:FDA to Pull Diabetes Drug Avandia From Pharmacy Shelves 2Health News:FDA to Pull Diabetes Drug Avandia From Pharmacy Shelves 3Health News:Important info about CHIPRA core set of recommended health care quality measures released 2Health News:Important info about CHIPRA core set of recommended health care quality measures released 3Health News:Important info about CHIPRA core set of recommended health care quality measures released 4Health News:Important info about CHIPRA core set of recommended health care quality measures released 5Health News:Swimmer's Ear Costs Up to $500 Million a Year in U.S. 2Health News:Many Women Can Have Cervical Cancer Test Every 3 Years: Study 2Health News:Many Women Can Have Cervical Cancer Test Every 3 Years: Study 3
CVC 223 is an assayed quality control material used for confirming the calibration and linearity of CO-Oximeter instrumentation....
... assayed quality control material used for monitoring the ... It is for specific use on Bayer analyzers ... 288, and 270) and the AVOX Systems CO-Oximeters ... used on the IRMA TRUpoint®. CC 527 is ...
... QC 623 is an assayed quality control material ... available in four (4) levels for monitoring analyzer ... It may be used on multiple test analyzers ... the Radiometer 600). QC623 is also for use ...
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens....
Medicine Products: